Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Longitudinal Study in Alzheimer Disease Diagnosis in Primary Consultants Patients With Cognitive and / or Memory Complaint Requiring Specialized Exploration Using AclarusDx® Blood Test in Memory Centers

NCT02221661 is registered in ClinicalTrials.gov with Diaxonhit as lead sponsor.

NCT NCT02221661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02221661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Longitudinal Study in Alzheimer Disease Diagnosis in Primary Consultants Patients With Cognitive and / or Memory Complaint Requiring Specialized Exploration Using AclarusDx® Blood Test in Memory Centers
Lead sponsor
Diaxonhit
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
December 31, 2013
Enrollment
606 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical investigation in memory centers, cognitive impairment, memory complaint